asia POLICY FORUM PRESENTATIONS
asia POLICY FORUM PRESENTATIONS
The following recordings and resources are provided for all HTAi members.
The main objective of the 2021 Global Policy Forum Annual Meeting panel session was to provide feedback from meeting discussions to the broader membership, enhance the debate, and advance collective thinking on the topic. This interactive panel session reported back and built upon the discussions from the 2021 Global Policy Forum.
DATE
Tuesday, June 22, 2021
PANELISTS:
Anne-Pierre Pickaert
Lynne Nakashima
Nicole Mittman
Francesco Pignatti
Seth Clancy
The meeting included the following items:
- An introductory presentation summarized the discussions and major outcomes of the GPF meeting in February.
- Reactions from HTA, industry, payer, and patient stakeholder representatives
The objective of this meeting was to discuss and refine the topic ahead of the 2022 HTAi Global Policy Forum in The Hague, The Netherlands (January 23-25, 2022).
DATE
Tuesday, June 8, 2021
The meeting included the following items:
- Reflections on the 2021 meeting proceedings, outputs, and follow-up
- An overview of the 2022 topic: “HTA 2025 and Beyond: Data Needs and Uncertainty Management in the Technology Lifecycle”
- Breakout Sessions
- Topic refinement discussion
- Meeting close – next steps
View breakout group #1 recording
View breakout group #2 recording
The objective of this webinar was to discuss and refine the topic ahead of the 2021 HTAi Global Policy Forum in The Hague, Netherlands (January 24-26, 2021).
DATE
Monday, June 8, 2020
PANELISTS:
Andrew Mitchell (Department of Health/PBAC/MSAC)
Wim Goettsch (ZIN)
Sulabha Ramachandran (GSK)
Vanessa Schaub (Roche)
The webinar included the following items:
- An overview of the 2021 topic: Novel Methods and Approaches for Conveying Uncertainty in HTA Findings to Multiple Stakeholders
- Panel to discuss topic scoping feedback
- Format of topic discussion during breakout groups
- Meeting close – next steps
Deliberative processes in HTA are arguably the only way to represent all stakeholder considerations in a fair and transparent fashion. Despite this, there is limited research on deliberation and no accepted minimum standards for their conduct. The prospects, problems and policy proposals for deliberative processes in HTA will be presented and expanded upon in this session. This panel session will report back and build upon the discussions from the 2020 Global Policy Forum and will include brief presentations from each speaker followed by vibrant group discussion.
DATE
Monday, June 22, 2020
PANELISTS:
Chair, HTAi Global Policy Forum: Dan Ollendorf, Tufts University Medical Center
Scientific Secretary, 2020 HTAi Global Policy Forum: Ken Bond, Institute Health Economics
Patient Representative: Valentina Strammiello, European Patients’ Forum
Marguerite Koster, Kaiser Permanente
Gesa Pellier, Novartis
Angel Link, National Health Care Institute – ZINL
More Resources
Deliberative processes in HTA are arguably the only way to represent all stakeholder considerations in a fair and transparent fashion. Despite this, there is limited research on deliberation and no accepted minimum standards for their conduct. The prospects, problems and policy proposals for deliberative processes in HTA will be presented and expanded upon in this session. This panel session will report back and build upon the discussions from the 2020 Global Policy Forum and will include brief presentations from each speaker followed by vibrant group discussion.
HTAi Global Policy Forum Panel – Presentation Slides (Wija Oortwijn)
HTAi is The ONLY Global Society Championing Equitable, Responsive, And Cutting-Edge Health Technology Assessment (HTA). As a community of multidisciplinary advisors, academics, scientists, professionals, public & private organizations, students, and citizen members.Everything we do is dedicated to better health for all people and the future of HTA worldwide.
Copyright © 2021. All Rights Reserved.
HTAi is The ONLY Global Society Championing Equitable, Responsive, And Cutting-Edge Health Technology Assessment (HTA). As a community of multidisciplinary advisors, academics, scientists, professionals, public & private organizations, students, and citizen members.Everything we do is dedicated to better health for all people and the future of HTA worldwide.
Copyright © 2021. All Rights Reserved.